Aaron B. Waxman
About
Aaron B. Waxman is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology.
According to data from OpenAlex, Aaron B. Waxman has authored 173 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Pulmonary and Respiratory Medicine, 80 papers in Cardiology and Cardiovascular Medicine and 18 papers in Molecular Biology. Recurrent topics in Aaron B. Waxman's work include Pulmonary Hypertension Research and Treatments (123 papers), Cardiovascular Function and Risk Factors (50 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers). Aaron B. Waxman is often cited by papers focused on Pulmonary Hypertension Research and Treatments (123 papers), Cardiovascular Function and Risk Factors (50 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers). Aaron B. Waxman collaborates with scholars based in United States, Brazil and France. Aaron B. Waxman's co-authors include David M. Systrom, Narasaiah Kolliputi, Alexander R. Opotowsky, Bradley A. Maron, Jack A. Elias, Manfred Steiner, Eugene J. Mark, Charles A. Hales, Olga Syrkina and Robert Homer and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.
In The Last Decade
Aaron B. Waxman
163 papers receiving 5.9k citations
Hit Papers
Peers
Aaron B. Waxman
Steeve Provencher Canada
Sanjay Mehta Canada
Laurent Savale France
James R. Klinger United States
Harm Jan Bogaard Netherlands
Charles A. Hales United States
Brian W. Christman United States
Elmo Mannarino Italy
Tohru Izumi Japan
Ludovic Drouet France
Citations per year, relative to Aaron B. Waxman Aaron B. Waxman (= 1×)
peers
Steeve Provencher
Countries citing papers authored by Aaron B. Waxman
Since
Specialization
Citations
This map shows the geographic impact of Aaron B. Waxman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron B. Waxman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron B. Waxman more than expected).
Fields of papers citing papers by Aaron B. Waxman
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Aaron B. Waxman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron B. Waxman. The network helps show where Aaron B. Waxman may publish in the future.
Co-authorship network of co-authors of Aaron B. Waxman
This figure shows the co-authorship network connecting the top 25 collaborators of Aaron B. Waxman. A scholar is included among the top collaborators of Aaron B. Waxman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron B. Waxman. Aaron B. Waxman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Systrom, David M., et al.. (2025). Impact of patient positioning on hemodynamic assessment: A comparison of supine and upright right heart catheterization. Physiological Reports. 13(20). e70632–e70632.
2.
El‐Kersh, Karim, Remzi Bag, Neel S. Bhatt, et al.. (2025). Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease. JHLT Open. 7. 100206–100206.
3.
Montani, David, Vallerie V. McLaughlin, J. Simon R. Gibbs, et al.. (2025). Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). American Journal of Respiratory and Critical Care Medicine. 211(6). 1028–1037.
4.
Rhodes, Christopher J., Lihan Zhou, Eileen M. Harder, et al.. (2025). Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension. Circulation Genomic and Precision Medicine. 18(3). e004862–e004862.
5.
Han, Qiao, Paul R. Forfia, Anjali Vaidya, et al.. (2023). Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study. Frontiers in Cardiovascular Medicine. 10. 1118796–1118796.
6.
Harder, Eileen M., Pietro Nardelli, James C. Ross, et al.. (2023). Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial Hypertension and Control Subjects. PubMed. 1(3). 100020–100020.
7.
Chopard, Romain, Umberto Campia, Lucas Morin, et al.. (2022). Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team. Journal of Thrombosis and Thrombolysis. 54(3). 449–460.
8.
Minhas, Jasleen, Pietro Nardelli, Nadine Al‐Naamani, et al.. (2021). Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism. Circulation Cardiovascular Imaging. 14(9). e012347–e012347.
9.
Nathan, Steven D., Victor F. Tapson, Jean Elwing, et al.. (2021). Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial. American Journal of Respiratory and Critical Care Medicine. 205(2). 198–207.
10.
Samokhin, Andriy O., Steven Hsu, Paul B. Yu, et al.. (2019). Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis. The Journal of Heart and Lung Transplantation. 39(4). 289–299.
11.
Schissler, Andrew J., et al.. (2018). Ultrasound‐assisted catheter‐directed thrombolysis compared with anticoagulation alone for treatment of intermediate‐risk pulmonary embolism. Pulmonary Circulation. 8(4). 1–7.
12.
McCabe, Colm, Rudolf K.F. Oliveira, Farbod N. Rahaghi, et al.. (2018). Right ventriculo–arterial uncoupling and impaired contractile reserve in obese patients with unexplained exercise intolerance. European Journal of Applied Physiology. 118(7). 1415–1426.
13.
Oldham, William M., Gregory D. Lewis, Alexander R. Opotowsky, Aaron B. Waxman, & David M. Systrom. (2016). Unexplained Exertional Dyspnea Caused by Low Ventricular Filling Pressures: Results from Clinical Invasive Cardiopulmonary Exercise Testing. Pulmonary Circulation. 6(1). 55–62.
14.
Landzberg, Michael J., et al.. (2015). Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. The Journal of Heart and Lung Transplantation. 35(2). 151–164.
15.
Maron, Bradley A., Alexander R. Opotowsky, Michael J. Landzberg, et al.. (2012). Plasma Aldosterone Levels are Elevated in Patients with Pulmonary Arterial Hypertension in the Absence of Left Ventricular Heart Failure: A Pilot Study. European Journal of Heart Failure. 15(3). 277–283.
16.
Kolliputi, Narasaiah, Rahamthulla S. Shaik, & Aaron B. Waxman. (2010). The Inflammasome Mediates Hyperoxia-Induced Alveolar Cell Permeability. The Journal of Immunology. 184(10). 5819–5826.
17.
Thibault, Hélène, Baptiste Kurtz, Michael J. Raher, et al.. (2010). 251 Non-invasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Archives of Cardiovascular Diseases Supplements. 2(1). 81–81.
18.
Tolle, James, et al.. (2008). Exercise-Induced Pulmonary Arterial Hypertension. Circulation. 118(21). 2183–2189.
19.
Steiner, Manfred, et al.. (2008). Interleukin-6 Overexpression Induces Pulmonary Hypertension. Circulation Research. 104(2). 236–244.
20.
Mann, Henry J., Robert C. Hyzy, Angela J. Rogers, et al.. (2008). Multicenter implementation of a consensus-developed, evidence-based, spontaneous breathing trial protocol*. Critical Care Medicine. 36(10). 2753–2762.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Steeve Provencher Breakdown of academic impact, for papers by Sanjay Mehta Breakdown of academic impact, for papers by Laurent Savale Breakdown of academic impact, for papers by James R. Klinger Breakdown of academic impact, for papers by Harm Jan Bogaard Breakdown of academic impact, for papers by Charles A. Hales Breakdown of academic impact, for papers by Brian W. Christman Breakdown of academic impact, for papers by Elmo Mannarino Breakdown of academic impact, for papers by Tohru Izumi Breakdown of academic impact, for papers by Ludovic Drouet